KAIMAX is a ready-for-use botulinum toxin type A injection, formulated to deliver targeted improvement of moderate to severe glabellar (frown) lines in adults aged 19–65.
Composition
Clostridium botulinum toxin type A (in-house): 100 U
Human serum albumin (EP): 0.5 mg
Sodium chloride (USP): 0.9 mg
Appearance & Reconstitution
Supplied as a white-to-light-yellow lyophilisate in a clear glass vial. Reconstitute with sterile, preservative-free 0.9 % sodium chloride:
Add 2.5 mL to yield 4 U/0.1 mL concentration
Gently swirl; avoid vigorous shaking or foaming
Label with date/time of reconstitution and use within 24 hours
Indications
Temporary reduction of moderate to severe glabellar lines
Improvement of forehead lines and crow’s feet
Masseter muscle treatment (e.g., bruxism, jaw clenching)
Adjunctive uses: sebum regulation and pore size reduction
Dosage & Administration
For glabellar lines, administer a total of 20 U via five intramuscular injection points, adjusting based on muscle mass and wrinkle severity. Follow clinical best practices for needle selection and injection technique.